Compugen Ltd. (CGEN)
NASDAQ: CGEN · Real-Time Price · USD
1.640
-0.070 (-4.09%)
Nov 4, 2024, 4:00 PM EST - Market closed
Compugen Employees
Compugen had 68 employees as of December 31, 2023. The number of employees decreased by 1 or -1.45% compared to the previous year.
Employees
68
Change (1Y)
-1
Growth (1Y)
-1.45%
Revenue / Employee
$628,235
Profits / Employee
-$140,132
Market Cap
146.84M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Repare Therapeutics | 179 |
Tenaya Therapeutics | 140 |
Adverum Biotechnologies | 121 |
EUDA Health Holdings | 106 |
Lineage Cell Therapeutics | 75 |
Verastem | 73 |
Vigil Neuroscience | 69 |
Galectin Therapeutics | 14 |
CGEN News
- 6 days ago - Compugen to Release Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 - PRNewsWire
- 4 weeks ago - Compugen to Present New Clinical Data at SITC 2024 - PRNewsWire
- 2 months ago - Compugen to Present at Single Cell Genomics 2024 Conference - PRNewsWire
- 2 months ago - Compugen to Present at the H.C. Wainwright 26th Annual Global Investment Conference - PRNewsWire
- 3 months ago - Compugen Ltd. (CGEN) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Compugen Reports Second Quarter 2024 Results - PRNewsWire
- 3 months ago - Compugen Announces FDA Clearance of IND for COM503 for the Treatment of Solid Tumors - PRNewsWire
- 3 months ago - Compugen to Release Second Quarter 2024 Results on Tuesday, August 6, 2024 - PRNewsWire